Evidence map›Paper›PMID 32038660›Full record

ArticleFrontiers in immunology2020

CD4 T Cell Determinants in West Nile Virus Disease and Asymptomatic Infection.

Maximilian Koblischke, Felicia S Spitzer, David M Florian, Stephan W Aberle, Stefan Malafa, Ingrid Fae, Irene Cassaniti, Christof Jungbauer, Bernhard Knapp, Hermann Laferl and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Cellular Immune Response in Horses After West Nile Neuroinvasive Disease.Animals : an open access journal from MDPI · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Maximilian KoblischkeCenter for Virology, Medical University of Vienna, Vienna, Austria.
Felicia S SpitzerCenter for Virology, Medical University of Vienna, Vienna, Austria.
David M FlorianCenter for Virology, Medical University of Vienna, Vienna, Austria.
Stephan W AberleCenter for Virology, Medical University of Vienna, Vienna, Austria.
Stefan MalafaCenter for Virology, Medical University of Vienna, Vienna, Austria.
Ingrid FaeDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
Irene CassanitiMolecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Christof JungbauerBlood Service for Vienna, Lower Austria and Burgenland, Austrian Red Cross, Vienna, Austria.
Bernhard KnappData Science Section, Symptoma GmbH, Vienna, Austria.
Hermann LaferlSozialmedizinisches Zentrum Süd, Kaiser-Franz-Josef-Spital, Vienna, Austria.
Gottfried FischerDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
Fausto BaldantiMolecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Karin StiasnyCenter for Virology, Medical University of Vienna, Vienna, Austria.
Franz X HeinzCenter for Virology, Medical University of Vienna, Vienna, Austria.
Judith H AberleCenter for Virology, Medical University of Vienna, Vienna, Austria.
Medical University of Vienna · ATAustrian Red Cross · ATIstituti di Ricovero e Cura a Carattere Scientifico · ITKaiser-Franz-Josef-Spital · ATPoliclinico San Matteo Fondazione · IT

Funding

Austrian Science Fund FWF P 29881Austrian Science Fund FWF P 29928
6 · The paper itself

Abstract

West Nile (WN) virus infection of humans is frequently asymptomatic, but can also lead to WN fever or neuroinvasive disease. CD4 T cells and B cells are critical in the defense against WN virus, and neutralizing antibodies, which are directed against the viral glycoprotein E, are an accepted correlate of protection. For the efficient production of these antibodies, B cells interact directly with CD4 helper T cells that recognize peptides from E or the two other structural proteins (capsid-C and membrane-prM/M) of the virus. However, the specific protein sites yielding such helper epitopes remain unknown. Here, we explored the CD4 T cell response in humans after WN virus infection using a comprehensive library of overlapping peptides covering all three structural proteins. By measuring T cell responses in 29 individuals with either WN virus disease or asymptomatic infection, we showed that CD4 T cells focus on peptides in specific structural elements of C and at the exposed surface of the pre- and postfusion forms of the E protein. Our data indicate that these immunodominant epitopes are recognized in the context of multiple different HLA molecules. Furthermore, we observed that immunodominant antigen regions are structurally conserved and similarly targeted in other mosquito-borne flaviviruses, including dengue, yellow fever, and Zika viruses. Together, these findings indicate a strong impact of virion protein structure on epitope selection and antigenicity, which is an important issue to consider in future vaccine design.

Indexed as

Asymptomatic InfectionsAdultAgedAntibodies, NeutralizingAntibodies, ViralCapsid ProteinsCD4-Positive T-LymphocytesCohort StudiesDengue VirusEpitopes, T-LymphocyteFemaleHLA-D AntigensHumansImmunodominant EpitopesMaleMiddle AgedAntibodies, NeutralizingAntibodies, ViralCapsid ProteinsEpitopes, T-LymphocyteHLA-D AntigensImmunodominant EpitopesPeptide LibraryRNA, ViralViral Envelope ProteinsCD4 T cellepitopeflavivirusimmunodominanceWest Nile patientsWest Nile virus

Identifiers

PMID32038660
PMCPMC6989424
OpenAlexW3000929269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.